| RS1680695228 |
MBD5
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS1680708290 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1680716624 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1680725785 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1680726399 |
MBD5
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS1680727391 |
HNRNPU
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1680764134 |
HNRNPU
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1680764227 |
HNRNPU
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1680778 |
ACAD9
|
Health Risk |
Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS1680874514 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1680921689 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1680928684 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1680930166 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1680936726 |
HNRNPU
|
Health Risk |
Pathogenic |
— |
| RS1681091117 |
CCDC88A
|
Health Risk |
Pathogenic |
— |
| RS1681104142 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1681105619 |
REEP1
|
Health Risk |
Likely pathogenic |
REEP1-related disorder, Hereditary spastic paraplegia 31 |
| RS1681107508 |
REEP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 31, Inborn genetic diseases |
| RS1681147109 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1681182291 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 2, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1681222021 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS1681356752 |
NPHP1
|
Health Risk |
Likely pathogenic |
Joubert syndrome with renal defect, Joubert syndrome with renal defect |
| RS1681409962 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, RYR2-related disorder |
| RS1681413798 |
WDPCP
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1681473896 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS1681478115 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS1681481862 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1681487356 |
MBD5
|
Health Risk |
Likely pathogenic |
— |
| RS1681530018 |
TBCE
|
Health Risk |
Pathogenic |
— |
| RS1681531187 |
TBCE
|
Health Risk |
Likely pathogenic |
Hypoparathyroidism-retardation-dysmorphism syndrome, Autosomal recessive Kenny-Caffey syndrome |
| RS1681536460 |
TBCE
|
Health Risk |
Pathogenic |
— |
| RS1681684655 |
DGUOK
|
Health Risk |
Likely pathogenic |
— |
| RS1681704644 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS1681763241 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1681835024 |
ST3GAL5
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, GM3 synthase deficiency |
| RS1681946262 |
EIF2B4
|
Health Risk |
Likely pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS1681971339 |
EIF2B4
|
Health Risk |
Pathogenic |
— |
| RS1681993062 |
GLI2
|
Health Risk |
Pathogenic |
Holoprosencephaly 9, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS1682014084 |
AFF3
|
Health Risk |
Likely pathogenic |
AFF3-associated disorder, AFF3-associated disorder |
| RS1682025430 |
EIF2B4
|
Health Risk |
Likely pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS1682104932 |
EIF2B4
|
Health Risk |
Likely pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS1682246203 |
EIF2B4
|
Health Risk |
Likely pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS1682321195 |
TTC7A
|
Health Risk |
Pathogenic |
Multiple gastrointestinal atresias, Gastrointestinal defects and immunodeficiency syndrome 1 |
| RS1682400034 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1682404578 |
RYR2
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS1682415237 |
CYP1B1
|
Health Risk |
Pathogenic |
Glaucoma 3A, Glaucoma 3A |
| RS1682416281 |
CYP1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital glaucoma, Congenital glaucoma |
| RS1682429616 |
CYP1B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Anterior segment dysgenesis 6, Inborn genetic diseases |
| RS1682430086 |
CYP1B1
|
Health Risk |
Pathogenic |
Congenital glaucoma, Congenital glaucoma |
| RS1682462329 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1682473914 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial dysautonomia, Familial dysautonomia |
| RS1682503990 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome 10, Noonan syndrome 2 |
| RS1682512619 |
CYP1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Anterior segment dysgenesis 6, Glaucoma 3A |
| RS1682561583 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1682567886 |
GLI2
|
Health Risk |
Pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Holoprosencephaly 9 |
| RS1682584195 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1682617375 |
MMADHC
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS1682617973 |
MMADHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS1682632400 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS1682638359 |
DGUOK
|
Health Risk |
Pathogenic |
— |
| RS1682706954 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS1682720062 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Singleton-Merten syndrome 1, Aicardi-Goutieres syndrome 7 |
| RS1682764315 |
MMADHC
|
Health Risk |
Pathogenic |
— |
| RS1682767587 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS1682776554 |
GLI2
|
Health Risk |
Pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS1682806219 |
MMADHC
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS1682810737 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Congenital myotonia |
| RS1682909859 |
BIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Myopathy |
| RS16830171 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS1683042337 |
ST3GAL5
|
Health Risk |
Pathogenic |
GM3 synthase deficiency, GM3 synthase deficiency |
| RS1683044033 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1683047204 |
ST3GAL5
|
Health Risk |
Pathogenic |
GM3 synthase deficiency, GM3 synthase deficiency |
| RS1683058752 |
B3GALNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS1683063437 |
PXDN
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 7, Anterior segment dysgenesis 7 |
| RS1683081860 |
GLI2
|
Health Risk |
Pathogenic |
— |
| RS1683090143 |
KYNU
|
Health Risk |
Likely pathogenic |
KYNU-related disorder, KYNU-related disorder |
| RS1683106396 |
PTH1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, PTH1R-related disorder |
| RS1683179008 |
GLI2
|
Health Risk |
Pathogenic |
Holoprosencephaly 9, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS1683179791 |
DGUOK
|
Health Risk |
Likely pathogenic |
— |
| RS1683184393 |
GLI2
|
Health Risk |
Pathogenic |
— |
| RS1683184865 |
GLI2
|
Health Risk |
Pathogenic/Likely pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Holoprosencephaly 9 |
| RS1683230082 |
GLI2
|
Health Risk |
Pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Holoprosencephaly 9 |
| RS1683256077 |
ITGB6
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1H, Amelogenesis imperfecta type 1H |
| RS1683278500 |
MECR
|
Health Risk |
Pathogenic |
— |
| RS1683280621 |
UBAP2L
|
Health Risk |
Pathogenic |
— |
| RS16832868 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Inborn genetic diseases |
| RS1683415081 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia, Catecholaminergic polymorphic ventricular tachycardia |
| RS1683477844 |
ZNF513
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1683490120 |
ZNF513
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 58, Retinitis pigmentosa 58 |
| RS16835020 |
ALG1
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1683515617 |
BBS5
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 5 |
| RS1683533087 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Singleton-Merten syndrome 1 |
| RS1683644409 |
BBS5
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 5, Bardet-Biedl syndrome 5 |
| RS1683644662 |
BBS5
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 5 |
| RS1683656584 |
NPHP1
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1683749371 |
NPHP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome with renal defect, Nephronophthisis |
| RS16838998 |
SON
|
Health Risk |
Conflicting classifications of pathogenicity |
ZTTK syndrome, ZTTK syndrome |
| RS1683920780 |
SLC25A12
|
Health Risk |
Likely pathogenic |
— |
| RS1683929269 |
CHRNA1
|
Health Risk |
Pathogenic |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS1683982622 |
LRP2
|
Health Risk |
Pathogenic |
— |